Skip to main content

Breadcrumb

  1. Home

Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

Integrated Community Based Health Systems Strengthening in Northern Togo

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Integrated Community Based Health Systems Strengthening in Northern Togo

NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial

Endocrine Response in Women With Invasive Lobular Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Endocrine Response in Women With Invasive Lobular Breast Cancer

Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 244
  • Page 245
  • Page 246
  • Page 247
  • Page 248
  • Page 249
  • Page 250
  • Page 251
  • Page 252
  • …
  • Next page Next
  • Last page Last
Subscribe to